"&#xa0;\n&#xa0;\nWritten evidence submitted on behalf of Roche Diagnostics UK (LTC 73)Summary&#xa0;\n&#xa0;\n&#xa0;\nIntroduction&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nWarfarin monitoring&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nDeep Vein Thrombosis&#xa0;\n&#xa0;\nDiabetes Care &#xa0;\n&#xa0;\n&#xa0;\nSelf-monitoring of blood glucose (SMBG) &#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nAccess to innovative blood glucose meters &#xa0;\nAccess to insulin pump therapy&#xa0;\nCommissioning support&#xa0;\nConclusion&#xa0;\n&#xa0;\nAbout Roche Diagnostics UK &#xa0;\nRoche Diabetes Care’s \nAccu-Chek\n® brand is the world leader in diabetes care, with a diverse portfolio of products designed to help people with diabetes live healthy, productive lives and to make managing diabetes easier.\n&#xa0;\nMay 2013\n \nWagner E (1998) ‘Chronic disease management: what will it take to improve care for chronic illness?’ Effective Clinical Practice, 1: 2-4\n \nKane R, R Priester and A Totten (2005) Meeting the Challenge of Chronic Illness, Baltimore: The John Hopkins University Press\n \nSobel D (1995) ‘Rethinking medicine: improving health outcomes with cost-effective psychosocial interventions’ Psychosomatic medicine, 57: 234-244\n \nKennedy A, et al (2007) ‘The effectiveness and cost effectiveness of a nationally led self-care support programme for patients with long term conditions: a pragmatic randomised control trial’ Journal of Epidemiology and Community Health 61(3): 254-261\n \nCampbell S, D Reeves, E Kontopantelis, E Middleton, B \nSibblad\n \nand M Roland (2007) ‘Quality of primary care in England with the introduction of pay for performance’ New England Journal of Medicine 357: 181-190\n \nHam C (2010) ‘The ten characteristics of the high-performing chronic care system’ Health Economics, Policy and Law 5: 71-90\n Gardiner et.al. Patient self-testing is a reliable and acceptable alternative to laboratory monitoring. Br J Haem 2004; 128:242-47\n Office for National Statistics 2008. Accessed 16 June 2011\n Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling [online]. Health Technol.Assess. 2007 ix-66; Oct;11(38):iii-iv, ix-66\n Heneghan C et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367(9508):404-11.\n Fitzmaurice DA et al. Self-Management of Oral Anticoagulation Therapy (SMART Trial). BMJ 2005; 331: 1057\n Atrial Fibrillation. Clinical Guideline No. 36. Costing Report NICE 2006\n This figure takes into account all secondary care costs, primary care costs and costs of the CoaguChek XS device and test strips\n S\necond report of session 2004-5 of The House of Commons Health Committee 'The Prevention of Venous Thromboembolism in Hospitalised Patients’\n NHS Local 2010 ‘Giving GPs power to decide on healthcare in Solihull – http://nhslocal.uk/story/features/giving-gps-power-decide-healthcare-solihull (accessed 19 March 2012)\n http://www.hscic.gov.uk/nda (accessed 7 May 2013)\n \nhttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/156336/Safe-care-of-people-with-type-1-diabetes.pdf.pdf (accessed 7 May 2013)\n Barnard K, Parkin C et al. Use of an automated bolus calculator reduces fear of hypoglycaemia and improves confidence in dosage accuracy in T1DM patients treated with multiple daily insulin injections., J Diabetes Sci Technol 2012;6:145–149\n"